Biotech Acquisition Co

Biotech Acquisition Co (Nasdaq: BIOT) is a blank-check company focused on the biotechnology and life sciences sector. The SPAC filed an 8-K with the Securities and Exchange Commission on January 25, 2023, accession number 0001213900-23-005142, reflecting material developments in its transaction timeline. As with all SPACs in the biotech space, BIOT is structured to identify and merge with a target company operating in the life sciences industry. The sponsor name associated with the vehicle has not been publicly disclosed in available filings. Investors tracking SPAC activity in the healthcare and biotech verticals can sign up at SpacDesk for full filing history, status updates, and deal analytics on BIOT and hundreds of other active vehicles.